Quantcast

Latest ImmusanT Inc. Stories

2011-05-09 07:00:00

CHICAGO, May 9, 2011 /PRNewswire/ -- ImmusanT, Inc., a biotechnology company developing an immunotherapeutic vaccine, companion diagnostic and monitoring tool for celiac disease, reported positive results from a Phase 1 study evaluating the safety, tolerability and bioactivity of Nexvax2® in patients with celiac disease.

2011-03-15 07:00:00

CAMBRIDGE, Mass., March 15, 2011 /PRNewswire/ -- Biotechnology company ImmusanT, Inc. today announced it has established its operations in Cambridge, Massachusetts and is advancing its strategy to develop an immunotherapeutic vaccine, companion diagnostic and monitoring tool for celiac disease.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related